Cytokine-Induced Injury of the Lacrimal and Salivary Glands
暂无分享,去创建一个
S. Akira | O. Mimura | H. Okamura | K. Nakanishi | S. Kashiwamura | H. Ueda | Tomohiro Ikeda | Akiko Kimura-Shimmyo | S. Kanno
[1] T. Billiar,et al. Molecular biology of nitric oxide synthases , 1998, Cancer and Metastasis Reviews.
[2] C. Moraes,et al. Lack of Oxidative Phosphorylation and Low Mitochondrial Membrane Potential Decrease Susceptibility to Apoptosis and Do Not Modulate the Protective Effect of Bcl-xL in Osteosarcoma Cells* , 2000, The Journal of Biological Chemistry.
[3] M. Kurimoto,et al. IFN-γ-Inducing Factor (IL-18) Increases Allergic Sensitization, Serum IgE, Th2 Cytokines, and Airway Eosinophilia in a Mouse Model of Allergic Asthma1 , 2000, The Journal of Immunology.
[4] C. Bogdan,et al. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. , 2000, Current opinion in immunology.
[5] M. Kurimoto,et al. IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. , 2000, Journal of immunology.
[6] S. Akira,et al. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Dayer,et al. Interleukin-18, rheumatoid arthritis, and tissue destruction. , 1999, The Journal of clinical investigation.
[8] J. Peychl,et al. The role of mitochondria in apoptosis induced in vitro. , 1999, General physiology and biophysics.
[9] K. Bauerová,et al. Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. , 1999, General physiology and biophysics.
[10] K. Tsubota,et al. Preferential Localization of CD8+ αEβ7+ T Cells Around Acinar Epithelial Cells with Apoptosis in Patients with Sjögren’s Syndrome , 1999, The Journal of Immunology.
[11] G. Kojda,et al. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. , 1999, Cardiovascular research.
[12] R. Pujol-Borrell,et al. Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome. , 1999, Journal of autoimmunity.
[13] H. Kolb,et al. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. , 1999, Journal of immunology.
[14] A. Fusco,et al. Bioactive IL-18 expression is up-regulated in Crohn's disease. , 1999, Journal of immunology.
[15] C. Lowenstein,et al. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription. , 1999, Journal of molecular biology.
[16] M. Humphreys-Beher,et al. The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome , 1999, Clinical and experimental immunology.
[17] C. Cooper,et al. Nitric oxide and iron proteins. , 1999, Biochimica et biophysica acta.
[18] H. Young,et al. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. , 1999, Journal of immunology.
[19] J. Harley,et al. Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins. , 1999, Arthritis and rheumatism.
[20] S. Akira,et al. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. , 1999, Journal of immunology.
[21] M. Lotz,et al. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. , 1999, Journal of immunology.
[22] C. Benoist,et al. Cellular and molecular changes accompanying the progression from insulitis to diabetes , 1999, European journal of immunology.
[23] C. Moskaluk,et al. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. , 1998, Journal of immunology.
[24] T. Yoshimoto. Interleukin-18 (IL-18), although anti-allergic when administered with IL-12, stimulates IL-4 and histamine release by basophils , 1999 .
[25] 兵頭 泰子. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor , 1999 .
[26] K. Tsubota,et al. Preferential localization of CD8+ alpha E beta 7+ T cells around acinar epithelial cells with apoptosis in patients with Sjögren's syndrome. , 1999, Journal of immunology.
[27] S. Youssef,et al. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis. , 1998, Journal of immunology.
[28] Theocharis,et al. Modes of epithelial cell death and repair in Sjögren's syndrome (SS) , 1998, Clinical and experimental immunology.
[29] A. Berra,et al. Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors. , 1998, Current eye research.
[30] G. Stoll,et al. Differential induction of interleukin-12, interleukin-18, and interleukin-1β converting enzyme mRNA in experimental autoimmune encephalomyelitis of the Lewis rat , 1998, Journal of Neuroimmunology.
[31] A. Lomniczi,et al. Role of Nitric Oxide in Salivary Secretion , 1998, Neuroimmunomodulation.
[32] H. Okamura,et al. Regulation of interferon-γ production by IL-12 and IL-18 , 1998 .
[33] Å. Sjöholm. Aspects of the involvement of interleukin-1 and nitric oxide in the pathogenesis of insulin-dependent diabetes mellitus , 1998, Cell Death and Differentiation.
[34] S. Akira,et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. , 1998, Immunity.
[35] J. Heesemann,et al. IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. , 1998, Journal of immunology.
[36] H. Okamura,et al. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. , 1998, Advances in immunology.
[37] N. Hogg. Free Radicals in Disease , 1998, Seminars in reproductive endocrinology.
[38] R. Fox. Sjögren's syndrome. Controversies and progress. , 1997, Clinics in laboratory medicine.
[39] J. Polak,et al. Role of nitric oxide in Sjögren's syndrome. , 1997, Arthritis and rheumatism.
[40] C. Janeway,et al. The Role of Fas in Autoimmune Diabetes , 1997, Cell.
[41] H. Kolb,et al. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. , 1997, The Journal of clinical investigation.
[42] I. Matsumoto,et al. TCR in Fas-sensitive T cells from labial salivary glands of patients with Sjögren's syndrome. , 1997, Journal of immunology.
[43] A. Bosi,et al. Ophthalmological Aspects in Allogenic Bone Marrow Transplantation: Sjögren-Like Syndrome in Graft-Versus-Host Disease , 1997, European journal of ophthalmology.
[44] W. M. Weaver,et al. The Proximal Regulatory Element of the Interferon-γ Promoter Mediates Selective Expression in T Cells* , 1996, The Journal of Biological Chemistry.
[45] J. Weidner,et al. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients , 1996, The Journal of experimental medicine.
[46] G. Matsuzaki,et al. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. , 1996, Arthritis and rheumatism.
[47] D. Carvajal,et al. IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses , 1996 .
[48] H. Okamura,et al. Cloning of a new cytokine that induces IFN-γ production by T cells , 1995, Nature.
[49] H. Moutsopoulos,et al. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. , 1995, British journal of rheumatology.
[50] S. Nagata,et al. Fas and Fas ligand: lpr and gld mutations. , 1995, Immunology today.
[51] F. Liew. Regulation of nitric oxide synthesis in infectious and autoimmune diseases. , 1994, Immunology letters.
[52] J. Stamler,et al. Redox signaling: Nitrosylation and related target interactions of nitric oxide , 1994, Cell.
[53] I. Weissman,et al. Expression of granzyme A in salivary gland biopsies from patients with primary Sjögren's syndrome. , 1994, Arthritis and rheumatism.
[54] J. Abrams,et al. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. , 1994, Journal of immunology.
[55] C. Nathan,et al. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide , 1993, The Journal of experimental medicine.
[56] S. Archer,et al. Measurement of nitric oxide in biological models , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[57] E. Ben-Chetrit. Target Antigens of the SSA/Ro and SSB/La System , 1992, American journal of reproductive immunology.
[58] N. Talal. Sjögren's syndrome: historical overview and clinical spectrum of disease. , 1992, Rheumatic diseases clinics of North America.
[59] M. Rudnicki,et al. Simplified mammalian DNA isolation procedure. , 1991, Nucleic acids research.